Compare Medpace Holdings Inc (MEDP) vs Western Union Co (WU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Western Union Co — how do they compare? Medpace Holdings Inc trades at $611.57 (market cap $16.82B), while Western Union Co trades at $6.15 (market cap $1.97B). The key difference: Medpace Holdings Inc is far larger — about 8.5× Western Union Co's market cap, and Western Union Co pays a 14.85% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Western Union Co for 96 Days on average.
| MEDP | WU | |
|---|---|---|
Market Cap | $16.82B | $1.97B |
Volume | 223,093 | 10,235,212 |
Sector | Health | Financials |
52-Week High | $630.19 | $10.28 |
52-Week Low | $393.42 | $5.90 |
Typical Hold Time | 14 Days | 96 Days |
Enterprise Value | $16.44B | $1.88B |
Dividend Yield | — | 14.85% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.
MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.
Western Union (WU) trades at $6.12, showing minimal daily movement with a 0.16% gain. The stock demonstrates strong profitability with a 43.97% ROE and attractive valuation metrics including a 5.1 P/E ratio. Recent earnings have been mixed with two misses in the last three quarters, while technical indicators show a bullish overall signal despite bearish moving averages. The company's $200 million efficiency plan and Intermex acquisition represent significant strategic initiatives.
WU presents a value opportunity with deep discount valuation, but faces earnings volatility and competitive pressures. The 12.24% analyst buy rating reflects cautious optimism, with the $6.86 consensus target offering 12% upside. Key risks include integration challenges from acquisitions and margin pressure from digital transformation costs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
